Tag: Lloyd Paul Aiello

Results of two large international clinical trials have shown positive results using Macugen, an experimental treatment that targets the abnormal blood vessels found in the “wet” form of macular degeneration. The results, described in November 2003 at the American Academy of Ophthalmology’s annual meeting in Anaheim, Calif., demonstrated the drug’s ability to decrease vision loss.…